Prevention of Postoperative Nausea and Vomiting Following General Anesthesia: An Evidence-Based Review of Pharmacological and Anesthetic Strategies
Abstract
Background and Aim: Postoperative nausea and vomiting (PONV) remains one of the most common and distressing complications following general anesthesia, affecting up to 30% of the general surgical population and up to 80% of high-risk patients. Beyond patient discomfort, PONV contributes to delayed post-anesthesia care unit discharge, unexpected hospital admission, dehydration, electrolyte imbalance, and surgical site complications. This review synthesizes current evidence on risk stratification, pharmacological prophylaxis, and anesthetic management strategies for PONV prevention.
Methods: Contemporary clinical practice guidelines, randomized controlled trials, and systematic reviews evaluating antiemetic pharmacotherapy and perioperative anesthetic techniques in adult surgical patients undergoing general anesthesia were reviewed and synthesized.
Results: Validated risk scoring systems, particularly the simplified Apfel score (female sex, non-smoking status, history of PONV or motion sickness, and postoperative opioid use), provide a practical framework for risk-adapted prophylaxis. First-line pharmacological agents acting on distinct receptor pathways include 5-HT3 receptor antagonists (e.g., ondansetron, palonosetron), corticosteroids (dexamethasone), neurokinin-1 (NK1) receptor antagonists (aprepitant, fosaprepitant), dopamine antagonists (droperidol, amisulpride), and anticholinergics (transdermal scopolamine). Combination therapy using two or more antiemetics from different pharmacological classes offers additive efficacy and is recommended for moderate-to-high-risk patients. Baseline anesthetic risk reduction strategies—including propofol-based total intravenous anesthesia (TIVA), avoidance of nitrous oxide and volatile anesthetics, regional anesthesia, and multimodal opioid-sparing analgesia—further reduce PONV incidence.
Conclusion: An evidence-based, multimodal approach combining preoperative risk assessment, baseline anesthetic modification (such as propofol TIVA and opioid minimization), and multi-receptor antiemetic prophylaxis is the cornerstone of effective PONV prevention in modern perioperative medicine.
Keywords
References
- Gan TJ, Belani KG, Bergese S, et al. Fourth Consensus Guidelines for the Management of Postoperative Nausea and Vomiting. Anesth Analg. 2020;131(2):411-448.
- Apfel CC, Läärä E, Koivuranta M, Greim CA, Roewer N. A simplified risk score for predicting postoperative nausea and vomiting: conclusions from cross-validations between two centers. Anesthesiology. 1999;91(3):693-700.
- Apfel CC, Korttila K, Abdalla M, et al. A factorial trial of six interventions for the prevention of postoperative nausea and vomiting. N Engl J Med. 2004;350(24):2441-2451.
- Weibel S, Rücker G, Eberhart LH, et al. Drugs for preventing postoperative nausea and vomiting in adults after general anaesthesia: a network meta-analysis. Cochrane Database Syst Rev. 2020;10(10):CD012859.
- Schraffordt Koops SE, Bisschop C, et al. Propofol-based total intravenous anesthesia versus volatile anesthesia for reducing postoperative nausea and vomiting: meta-analysis of randomized trials. Br J Anaesth. 2019;122(4):442-451.
- DREAMS Trial Collaborators and West Midlands Research Collaborative. Dexamethasone versus standard treatment for postoperative nausea and vomiting in gastrointestinal surgery: randomised controlled trial (DREAMS Trial). BMJ. 2017;357:j1455.
- Kranke P, Meybohm P, Diemunsch P, et al. Amisulpride prevents postoperative nausea and vomiting in patients at high risk: a randomized, double-blind, placebo-controlled trial. Anesthesiology. 2018;128(6):1099-1106.
- visram A, Habib AS. Multimodal antiemetic prophylaxis and opioid-sparing strategies in enhanced recovery after surgery (ERAS) pathways. Curr Opin Anaesthesiol. 2021;34(6):710-717.